Figure 3.

Evolution of CRT measured by optical coherence tomography (y-axis) from baseline through to 6 months in patients who received (A) unilateral therapy, (B) bilateral therapy (eye that was initially treated), (C) bilateral therapy (eye treated contralaterally) and (D) unilateral therapy (according to the total number of injections received). Results of baseline and follow-up assessments (visits 1 to 6) are presented and all visits are 1 month apart. Pairwise comparisons for unilateral therapy showed significant differences from baseline at V3 (P=0.007) and V6 (P=0.027). The interpolation line connects the median value of CRT between the visits and the data points (small circles/plus symbols) correspond to outliers. ^*P<0.05; ^**P<0.01 CRT, central retinal thickness; V, visit; n.s., not significant.